Advanced search
Publication Cover
Biomarkers in Medicine Volume 13, 2019 - Issue 8
Submit an article Journal homepage
1,374
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Unlocking the Translational Potential of Circulating Nucleosomes for Liquid Biopsy in Diffuse Intrinsic Pontine Glioma

Victor M Lu1 Department of Neurologic Surgery, Mayo Clinic, Rochester, MN55905, USAView further author information
,
Erica A Power1 Department of Neurologic Surgery, Mayo Clinic, Rochester, MN55905, USA;2 Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN55905, USAView further author information
,
Liang Zhang1 Department of Neurologic Surgery, Mayo Clinic, Rochester, MN55905, USAView further author information
&
David J Daniels1 Department of Neurologic Surgery, Mayo Clinic, Rochester, MN55905, USACorrespondence[email protected]
View further author information
Pages 597-600 | Received 02 Apr 2019, Accepted 03 Apr 2019, Published online: 03 Jun 2019

References

  • Merchant TE , PollackIF, LoefflerJS. Brain tumors across the age spectrum: biology, therapy, and late effects. Seminars Radiation Oncol.20(1), 58–66 (2010).
  • Wu G , BroniscerA, McEachronTAet al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet.44(3), 251–253 (2012).
  • Castel D , PhilippeC, KergrohenTet al. Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas, H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Acta Neuropathol. Commun.6(1), 117 (2018).
  • Louis DN , OhgakiH, WiestlerOD, CaveneeWK. WHO Classification of Tumours of the Central Nervous System, Revised. Fourth Edition.IARC Press, Lyon, France (2016).
  • Castel D , PhilippeC, CalmonRet al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol.130(6), 815–827 (2015).
  • Maury E , HashizumeR. Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: insight into epigenetic therapies. Epigenetics12(5), 353–369 (2017).
  • Chan KM , FangD, GanHet al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev.27(9), 985–990 (2013).
  • Fang D , GanH, ChengLet al. H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers. eLife1, 7 (2018).
  • Buczkowicz P , BartelsU, BouffetE, BecherO, HawkinsC. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol.128(4), 573–581 (2014).
  • Pathak P , JhaP, PurkaitSet al. Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM. J. Neuro-oncol.121(3), 489–497 (2015).
  • Lau PNI , CheungP. Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing. Proc. Natl Acad. Sci. USA108(7), 2801 (2011).
  • Gupta N , GoumnerovaLC, ManleyPet al. Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro-oncology20(11), 1547–1555 (2018).
  • Traylor JI , KuoJS. “Liquid biopsy” of circulating tumor DNA characterizes treatment response in pediatric patients diffuse midline glioma. Neurosurgerydoi: https://doi.org/10.1093/neuros/nyz029 (2019) (Epub ahead of print).
  • Pan C , DiplasBH, ChenXet al. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Acta Neuropathol.137(2), 297–306 (2019).
  • Huang TY , PiuntiA, LullaRRet al. Detection of histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol. Commun.5(1), 28 (2017).
  • McAnena P , BrownJA, KerinMJ. Circulating nucleosomes and nucleosome modifications as biomarkers in cancer. Cancers9(1), 1–18 (2017).
  • Gezer U , YorukerEE, KeskinM, KulleCB, DharumanY, HoldenriederS. Histone methylation marks on circulating nucleosomes as novel blood-based biomarker in colorectal cancer. Internat. J. Mol. Sci.16(12), 29654–29662 (2015).
  • Syren P , AnderssonR, BaudenM, AnsariD. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma. Scandinavian J. Gastroenterolo.52(6–7), 668–673 (2017).
  • Wetmore C , BoyettJ, LiSet al. Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children. Neuro-oncology17(6), 882–888 (2015).
  • Hashizume R . Epigenetic targeted therapy for diffuse intrinsic pontine glioma. Neurol. Medico-chirurgica57(7), 331–342 (2017).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.